Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02EHY
|
||||
Former ID |
DIB018558
|
||||
Drug Name |
2MD
|
||||
Synonyms |
VDZ; 2-methylene-19-nor-(20S)-1 alpha,25-dihydroxy-vitamin D3
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539821] | ||
Structure |
Download2D MOL |
||||
Formula |
C27H44O3
|
||||
InChI |
InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)22-12-13-23-21(9-7-15-27(22,23)5)11-10-20-16-24(28)19(2)25(29)17-20/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b21-11+/t18-,22+,23-,24+,25+,27+/m0/s1
|
||||
InChIKey |
UHMPCVGLSKFXHR-NAQZCRMNSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Vitamin D receptor | Target Info | Agonist | [534740] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PANTHER Pathway | Vitamin D metabolism and pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.